228 related articles for article (PubMed ID: 12893818)
1. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G
J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation.
Maiti B; Li J; de Bruin A; Gordon F; Timmers C; Opavsky R; Patil K; Tuttle J; Cleghorn W; Leone G
J Biol Chem; 2005 May; 280(18):18211-20. PubMed ID: 15722552
[TBL] [Abstract][Full Text] [Related]
3. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
4. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
Di Stefano L; Jensen MR; Helin K
EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
[TBL] [Abstract][Full Text] [Related]
5. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
[TBL] [Abstract][Full Text] [Related]
6. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
[TBL] [Abstract][Full Text] [Related]
7. Activity of the human cytochrome c1 promoter is modulated by E2F.
Luciakova K; Barath P; Li R; Zaid A; Nelson BD
Biochem J; 2000 Oct; 351(Pt 1):251-6. PubMed ID: 10998368
[TBL] [Abstract][Full Text] [Related]
8. E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains.
Logan N; Delavaine L; Graham A; Reilly C; Wilson J; Brummelkamp TR; Hijmans EM; Bernards R; La Thangue NB
Oncogene; 2004 Jul; 23(30):5138-50. PubMed ID: 15133492
[TBL] [Abstract][Full Text] [Related]
9. Atypical E2F repressors and activators coordinate placental development.
Ouseph MM; Li J; Chen HZ; Pécot T; Wenzel P; Thompson JC; Comstock G; Chokshi V; Byrne M; Forde B; Chong JL; Huang K; Machiraju R; de Bruin A; Leone G
Dev Cell; 2012 Apr; 22(4):849-62. PubMed ID: 22516201
[TBL] [Abstract][Full Text] [Related]
10. DNA-damage response control of E2F7 and E2F8.
Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
[TBL] [Abstract][Full Text] [Related]
11. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
[TBL] [Abstract][Full Text] [Related]
13. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A
Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653
[TBL] [Abstract][Full Text] [Related]
14. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence.
Aksoy O; Chicas A; Zeng T; Zhao Z; McCurrach M; Wang X; Lowe SW
Genes Dev; 2012 Jul; 26(14):1546-57. PubMed ID: 22802529
[TBL] [Abstract][Full Text] [Related]
15. E2F-4, a new member of the E2F transcription factor family, interacts with p107.
Ginsberg D; Vairo G; Chittenden T; Xiao ZX; Xu G; Wydner KL; DeCaprio JA; Lawrence JB; Livingston DM
Genes Dev; 1994 Nov; 8(22):2665-79. PubMed ID: 7958924
[TBL] [Abstract][Full Text] [Related]
16. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
17. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Cartwright P; Müller H; Wagener C; Holm K; Helin K
Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
[TBL] [Abstract][Full Text] [Related]
18. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
Chong JL; Wenzel PL; Sáenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G
Nature; 2009 Dec; 462(7275):930-4. PubMed ID: 20016602
[TBL] [Abstract][Full Text] [Related]
19. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
[TBL] [Abstract][Full Text] [Related]
20. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.
Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A
Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
